论文部分内容阅读
目的探讨小剂量肝素钙对新生儿硬肿症的治疗作用及安全性。方法治疗组与对照组各 6 3例。两组均常规复温、纠酸扩容、抗感染、补充热量及血管活性药物等综合治疗。治疗组在上述基础上加用肝素钙 ,剂量10～ 12 .5u/ (kg·次 ) ,每 12h 1次 ,皮下注射。结果小剂量肝素钙治疗组较对照组硬肿消退时间明显缩短 ,两组疗效差异有显著性 ,治疗过程中无毒副作用。结论小剂量肝素钙皮下注射治疗新生儿硬肿症是安全有效的方法。
Objective To investigate the therapeutic effect and safety of low-dose heparin calcium on neonatal sclera. Methods The treatment group and the control group of 63 cases. Both groups were routine rewarming, correcting acid expansion, anti-infective, heat and vasoactive drugs and other comprehensive treatment. In the treatment group, heparin calcium was added on the basis of the above, and the dose was 10-12.5 u / (kg · time), once every 12 hours, subcutaneously. Results Small dose of heparin calcium treatment group compared with the control group, the edema time was significantly shorter, the difference between the two groups was significant, no toxic side effects during treatment. Conclusion The low-dose heparin calcium subcutaneous injection in the treatment of neonatal sclera is a safe and effective method.